Effects of dark chocolate and cocoa consumption on endothelial function and arterial stiffness in overweight adults

British Journal of Nutrition

Volumn 111, Issue 4, 2014, Pages 653-661

  West, Sheila G ^a   McIntyre, Molly D ^a   Piotrowski, Matthew J ^a   Poupin, Nathalie ^b   Miller, Debra L ^c   Preston, Amy G ^c   Wagner, Paul ^a   Groves, Lisa F ^a   Skulas Ray, Ann C ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b CENTRE MAURICE HALBWACHS   (France)

^c The Hershey Company   (United States)

Author keywords

Chocolate; Cocoa; Endothelium; Flow mediated dilation

Indexed keywords

ADULT; BLOOD PRESSURE; BRACHIAL ARTERY; CACAO; CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FASTING; FEMALE; FLAVONOIDS; HUMANS; HYPEREMIA; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PHYTOTHERAPY; PLANT PREPARATIONS; SEX FACTORS; VASCULAR STIFFNESS; VASODILATION;

C REACTIVE PROTEIN; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; FLAVANOID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SATURATED FATTY ACID; SUGAR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTERIAL STIFFNESS; ARTERY DIAMETER; ARTICLE; AUGMENTATION INDEX; BLOOD FLOW VOLUME; BLOOD VESSEL PARAMETERS; BODY WEIGHT; BRACHIAL ARTERY; CACAO; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DARK CHOCOLATE; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; FEMALE; FLOW MEDIATED DILATION; GLUCOSE BLOOD LEVEL; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PERIPHERAL CIRCULATION; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REACTIVE HYPEREMIA INDEX; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM; VASODILATATION;

THEOBROMA CACAO;

EID: 84894083142     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513002912     Document Type: Article

References (59)

1. Vanhoutte PM, Shimokawa H, Tang EH, et al. (2009) Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196, 193-222.
2. Vita JA (2003) Tea consumption and cardiovascular disease: effects on endothelial function. J Nutr 133, 3293S-3297S.
3. Ras RT, Zock PL & Draijer R (2011) Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis. PLoS One 6, e16974.
4. Coimbra SR, Lage SH, Brandizzi L, et al. (2005) The action of red wine and purple grape juice on vascular reactivity is independent of plasma lipids in hypercholesterolemic patients. Braz J Med Biol Res 38, 1339-1347.
5. Andrade AC, Cesena FH, Consolim-Colombo FM, et al. (2009) Short-term red wine consumption promotes differential effects on plasma levels of high-density lipoprotein cholesterol, sympathetic activity, and endothelial function in hypercholesterolemic, hypertensive, and healthy subjects. Clinics (Sao Paulo) 64, 435-442.
6. Fisher ND, Hughes M, Gerhard-Herman M, et al. (2003) Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens 21, 2281-2286.
7. Heiss C, Dejam A, Kleinbongard P, et al. (2003) Vascular effects of cocoa rich in flavan-3-ols. JAMA 290, 1030-1031.
8. Engler MB, Engler MM, Chen CY, et al. (2004) Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr 23, 197-204.
9. Farouque HM, Leung M, Hope SA, et al. (2006) Acute and chronic effects of flavanol-rich cocoa on vascular function in subjects with coronary artery disease: a randomized double-blind placebo-controlled study. Clin Sci (Lond) 111, 71-80.
10. Heiss C, Finis D, Kleinbongard P, et al. (2007) Sustained increase in flow-mediated dilation after daily intake of highflavanol cocoa drink over 1 week. J Cardiovasc Pharmacol Ther 49, 74-80.
11. Balzer J, Rassaf T, Heiss C, et al. (2008) Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients: a double-masked, randomized, controlled trial. J Am Coll Cardiol 51, 2141-2149.
12. Monahan KD, Feehan RP, Kunselman AR, et al. (2011) Dosedependent increases in flow-mediated dilation following acute cocoa ingestion in healthy older adults. J Appl Physiol 111, 1568-1574.
13. Njike VY, Faridi Z, Shuval K, et al. (2011) Effects of sugarsweetened and sugar-free cocoa on endothelial function in overweight adults. Int J Cardiol 149, 83-88.
14. Shrime MG, Bauer SR, McDonald AC, et al. (2011) Flavonoidrich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J Nutr 141, 1982-1988.
15. Vlachopoulos C, Aznaouridis K, Alexopoulos N, et al. (2005) Effect of dark chocolate on arterial function in healthy individuals. Am J Hypertens 18, 785-791.
16. Schroeter H, Heiss C, Balzer J, et al. (2006) Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 103, 1024-1029.
17. Faridi Z, Njike VY, Dutta S, et al. (2008) Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial. Am J Clin Nutr 88, 58-63.
18. Davison K, Coates AM, Buckley JD, et al. (2008) Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes 32, 1289-1296.
19. Knorr M, Hausding M, Kroller-Schuhmacher S, et al. (2011) Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan. Arterioscler Thromb Vasc Biol 31, 2223-2231.
20. Vlachopoulos CV, Alexopoulos NA, Aznaouridis KA, et al. (2007) Relation of habitual cocoa consumption to aortic stiffness and wave reflections, and to central hemodynamics in healthy individuals. Am J Cardiol 99, 1473-1475.
21. Nichols WW & Epstein BJ (2009) Actions of selected cardiovascular hormones on arterial stiffness and wave reflections. Curr Pharm Des 15, 304-320.
22. Payne M, Hurst W, Stuart D, et al. (2010) Determination of total procyanidins in selected chocolate and confectionery products using DMAC. J AOAC Int 93, 89-96.
23. Heffernan KS, Kuvin JT, Sarnak MJ, et al. (2011) Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 26, 2515-2521.
24. Patvardhan E, Heffernan KS, Ruan J, et al. (2011) Augmentation index derived from peripheral arterial tonometry correlates with cardiovascular risk factors. Cardiol Res Pract 2011, 253758.
25. Recio-Rodriguez JI, Gomez-Marcos MA, Patino-Alonso MC, et al. (2012) Cocoa intake and arterial stiffness in subjects with cardiovascular risk factors. Nutr J 11, 8.
26. Ou B, Hampsch-Woodill M & Prior RL (2001) Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J Agric Food Chem 49, 4619-4626.
27. Huang D, Ou B, Hampsch-Woodill M, et al. (2002) Development and validation of oxygen radical absorbance capacity assay for lipophilic antioxidants using randomly methylated beta-cyclodextrin as the solubility enhancer. J Agric Food Chem 50, 1815-1821.
28. Singleton VL & Rossi JA (1965) Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic 16, 144-158.
29. Nelson BC & Sharpless KE (2003) Quantification of the predominant monomeric catechins in baking chocolate standard reference material by LC/APCI-MS. J Agric Food Chem 51, 531-537.
30. Hurst W, Stanley B, Glinski J, et al. (2009) Characterization of primary standards for use in the HPLC analysis of the procyanidin content of cocoa and chocolate containing products. Molecules 14, 4136-4146.
31. Robbins RJ, Leonczak J, Johnson JC, et al. (2009) Method performance and multi-laboratory assessment of a normal phase high pressure liquid chromatography-fluorescence detection method for the quantitation of flavanols and procyanidins in cocoa and chocolate containing samples. J Chroma A 1216, 4831-4840.
32. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health and Nutrition Examination Survey Data & Hyattsville MUSDoH (1994) Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1, 1-407.
33. Baba S, Osakabe N, Yasuda A, et al. (2000) Bioavailability of (2)-epicatechin upon intake of chocolate and cocoa in human volunteers. Free Radic Res 33, 635-641.
34. Celermajer DS, Sorensen KE, Gooch VM, et al. (1992) Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340, 1111-1115.
35. West SG, Wagner P, Schoemer SL, et al. (2004) Biological correlates of day-to-day variation in flow-mediated dilation in individuals with type 2 diabetes: a study of test-retest reliability. Diabetologia 47, 1625-1631.
36. West SG, Hecker KD, Mustad VA, et al. (2005) Acute effects of monounsaturated fatty acids with and without omega-3 fatty acids on vascular reactivity in individuals with type 2 diabetes. Diabetologia 48, 113-122.
37. Bonetti PO, Pumper GM, Higano ST, et al. (2004) Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 44, 2137-2141.
38. McCrea CE, Skulas-Ray AC, Chow M, et al. (2012) Test-retest reliability of pulse amplitude tonometry measures of vascular endothelial function: implications for clinical trial design. Vasc Med 17, 29-36.
39. Rubinshtein R, Kuvin JT, Soffler M, et al. (2010) Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 31, 1142-1148.
40. Hamburg N, Keyes M & Larson M (2008) Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 117, 2467-2474.
41. Hamburg NM & Benjamin EJ (2009) Assessment of endothelial function using digital pulse amplitude tonometry. Trends Cardiovasc Med 19, 6-11.
42. Wilkinson IB, MacCallum H, Flint L, et al. (2000) The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 525, 263-270.
43. Persson IA, Persson K, Hagg S, et al. (2011) Effects of cocoa extract and dark chocolate on angiotensin-converting enzyme and nitric oxide in human endothelial cells and healthy volunteers-a nutrigenomics perspective. J Cardiovasc Pharmacol 57, 44-50.
44. Morgan C & Lazarow A (1963) Immunoassay of insulin: two antibody system. Plasma insulin levels in normal, subdiabetic, and diabetic rats. Diabetes 12, 115-126.
45. Bonora E, Formentini G, Calcaterra F, et al. (2002) HOMAestimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 25, 1135-1141.
46. Hooper L, Kroon PA, Rimm EB, et al. (2008) Flavonoids, flavonoid rich foods, and cardiovascular risk: a meta analysis of randomized trials. Am J Clin Nutr 88, 38-50.
47. Karim M, McCormick K & Kappagoda CT (2000) Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr 130, 2105S-2108S.
48. Schnorr O, Brossette T, Momma TY, et al. (2008) Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo. Arch Biochem Biophys 476, 211-215.
49. Ottaviani JI, Momma TY, Heiss C, et al. (2011) The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo. Free Radic Biol Med 50, 237-244.
50. Loke WM, Hodgson JM, Proudfoot JM, et al. (2008) Pure dietary flavonoids quercetin and (2)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 88, 1018-1025.
51. Heiss C, Kleinbongard P, Dejam A, et al. (2005) Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol 46, 1276-1283.
52. Fisher ND & Hollenberg NK (2006) Aging and vascular responses to flavanol-rich cocoa. J Hypertens 24, 1575-1580.
53. Crews WD Jr, Harrison DW & Wright JW (2008) A doubleblind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults. Am J Clin Nutr 87, 872-880.
54. Ried K, Sullivan T, Fakler P, et al. (2010) Does chocolate reduce blood pressure? A meta-analysis. BMC Med 8, 39.
55. Grassi D, Necozione S, Lippi C, et al. (2005) Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 46, 398-405.
56. Grassi D, Desideri G, Necozione S, et al. (2008) Blood pressure is reduced and insulin sensitivity increased in glucoseintolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr 138, 1671-1676.
57. Berry NM, Davison K, Coates AM, et al. (2010) Impact of cocoa flavanol consumption on blood pressure responsivenes to exercise. Br J Nutr 103, 1480-1484.
58. Gosmanov AR, Smiley DD, Robalino G, et al. (2010) Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects. Am J Phys Endocrinol Metab 299, E953-E958.
59. Hooper L, Kay C, Abdelhamid A, et al. (2012) Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr 95, 740-751.